DM Hoang
Stem cell-based therapy for human diseases.
Hoang, DM; Pham, PT; Bach, TQ; Ngo, ATL; Nguyen, QT; Phan, TTK; Nguyen, GH; Nguyen, LT; Le, PTT; Hoang, VT; Forsyth, NR; Heke, M
Authors
PT Pham
TQ Bach
ATL Ngo
QT Nguyen
TTK Phan
GH Nguyen
LT Nguyen
PTT Le
VT Hoang
NR Forsyth
M Heke
Abstract
Recent advancements in stem cell technology open a new door for patients suffering from diseases and disorders that have yet to be treated. Stem cell-based therapy, including human pluripotent stem cells (hPSCs) and multipotent mesenchymal stem cells (MSCs), has recently emerged as a key player in regenerative medicine. hPSCs are defined as self-renewable cell types conferring the ability to differentiate into various cellular phenotypes of the human body, including three germ layers. MSCs are multipotent progenitor cells possessing self-renewal ability (limited in vitro) and differentiation potential into mesenchymal lineages, according to the International Society for Cell and Gene Therapy (ISCT). This review provides an update on recent clinical applications using either hPSCs or MSCs derived from bone marrow (BM), adipose tissue (AT), or the umbilical cord (UC) for the treatment of human diseases, including neurological disorders, pulmonary dysfunctions, metabolic/endocrine-related diseases, reproductive disorders, skin burns, and cardiovascular conditions. Moreover, we discuss our own clinical trial experiences on targeted therapies using MSCs in a clinical setting, and we propose and discuss the MSC tissue origin concept and how MSC origin may contribute to the role of MSCs in downstream applications, with the ultimate objective of facilitating translational research in regenerative medicine into clinical applications. The mechanisms discussed here support the proposed hypothesis that BM-MSCs are potentially good candidates for brain and spinal cord injury treatment, AT-MSCs are potentially good candidates for reproductive disorder treatment and skin regeneration, and UC-MSCs are potentially good candidates for pulmonary disease and acute respiratory distress syndrome treatment.
Acceptance Date | Jul 21, 2022 |
---|---|
Publication Date | Aug 6, 2022 |
Publicly Available Date | Mar 29, 2024 |
Journal | Signal Transduction and Targeted Therapy |
Print ISSN | 2059-3635 |
Publisher | Springer Nature [academic journals on nature.com] |
Pages | 272 - ? |
DOI | https://doi.org/10.1038/s41392-022-01134-4 |
Keywords | mesenchymal stem cells; stem cell research |
Publisher URL | https://www.nature.com/articles/s41392-022-01134-4#author-information |
Files
Stem cell-based therapy for human diseases.pdf
(4.3 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Human Mesenchymal Stem Cell Secretome Driven T Cell Immunomodulation Is IL-10 Dependent
(2022)
Journal Article
Decellularised Pleural Membrane Patches In Pulmonary Regenerative Medicine
(2022)
Conference Proceeding
EPITHELIAL-TO-MESENCHYMAL TRANSITION FOR STEMNESS CONTROL AND BIOENGINEERING STRATEGIES
(2022)
Conference Proceeding
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search